Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation

Author(s):: Nout, R.A.; Bosse, T.; Creutzberg, C.L. (0000-0002-7008-4321); Jurgenliemk-Schulz, I.M.; Jobsen, J.J.; Lutgens, L.C.H.W.; Steen-Banasik, E.M. van der; Eijk, R. van; Haar, N.T. ter; Smit, V.T.H.B.M.

Published: 2012
Publication type: Article / Letter to editor

Date issued: 2012
Language: English
Is part of: Gynecologic Oncology
hdl: 1887/3281733
doi: 10.1016/j.ygyno.2012.05.012
URL: http://europepmc.org/abstract/med/22609107